Biofrontera (BFRIW) Gains from Investment Securities (2020 - 2025)

Biofrontera's Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $442000.0 for Q4 2025.

• In Q4 2025, Gains from Investment Securities fell 68.06% year-over-year to $442000.0; the TTM figure through Dec 2025 stood at $2.0 million (down 73.92% YoY), while the FY2025 annual figure was $719844.0, down 44.2% from the prior year.
• Gains from Investment Securities was $442000.0 for Q4 2025 at Biofrontera, up from $285000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.8 billion in Q3 2022 to a low of -$1.0 million in Q1 2023.
• Historically, Gains from Investment Securities has averaged $174.8 million across 5 years, with a median of $186266.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities soared 81573900.0% in 2022, then sank 3722.52% in 2023.
• A 5-year view of Gains from Investment Securities shows it stood at $47000.0 in 2021, then jumped by 38044.68% to $17.9 million in 2022, then sank by 88.76% to $2.0 million in 2023, then sank by 31.35% to $1.4 million in 2024, then plunged by 68.06% to $442000.0 in 2025.
• The last three Gains from Investment Securities figures came in at $442000.0 (Q4 2025), $285000.0 (Q3 2025), and -$153000.0 (Q2 2025), per Business Quant data.